$52.9 1.1 2.2%
Last Trade - 12/04/21
| Market Cap | £1.92bn |
| Enterprise Value | £1.86bn |
| Revenue | £1.88bn |
| Position in Universe | 1992nd / 6825 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2,247 | 2,208 | 2,279 | 2,679 | 2,420 | 2,582 | 2,795 | 2,903 | +2.8% | ||
| -27.5 | +13.2 | +26.6 | -11.7 | +8.8 | +16.9 | +10.3 | +7.35 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Nu Skin Enterprises, Inc. is a holding company. The Company through Nu Skin, a global direct selling company is engaged in developing and distributing personal care products and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products, which includes 180 System, AP 24, Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White, Tru Face and Sunright. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. Its ageLOC provides anti-aging products, which includes Facial Spa, Me, LumiSpa, TFEU and Transformation products. The Company operates through nine segments, which consists of seven geographic Nu Skin segments, including Mainland China, South Korea, Southeast Asia, Americas/Pacific, Hong Kong/Taiwan, Europe, Middle East and Africa (EMEA), and Japan. Its segments also include Manufacturing segment and Grow Tech segment.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | September 4, 1996 |
| Public Since | November 22, 1996 |
| No. of Shareholders: | 245 |
| No. of Employees: | 5,000 |
| Sector | Consumer Defensives |
| Industry | Personal & Household Products & Services |
| Index | S&P 400 Mid Cap , S&P Composite 1500 , |
| Exchange | New York Stock Exchange |
| Shares in Issue | 50,844,332 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 75 W Center St, PROVO, 84601-4432, United States |
| Web | https://www.nuskin.com/ |
| Phone | +1 801 3451000 |
| Contact | () |
| Auditors | PricewaterhouseCoopers LLP |
As of 12/04/21, shares in NU Skin Enterprises Inc are trading at $52.9, giving the company a market capitalisation of £1.92bn. This share price information is delayed by 15 minutes.
Shares in NU Skin Enterprises Inc are currently trading at $52.9 and the price has moved by 0.134k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the NU Skin Enterprises Inc price has moved by 57.43% over the past year.
Of the analysts with advisory recommendations for NU Skin Enterprises Inc, there are there are currently 1 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for NU Skin Enterprises Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.
NU Skin Enterprises Inc is scheduled to issue upcoming financial results on the following dates:
The NU Skin Enterprises Inc dividend yield is 2.9% based on the trailing twelve month period.
Last year, NU Skin Enterprises Inc paid a total dividend of 1.5, and it currently has a trailing dividend yield of 2.9%. Looking ahead, NU Skin Enterprises Inc has not announced an ex-dividend date yet.
NU Skin Enterprises Inc has yet to annouce their ex-dividend date. The historic dividend yield on NU Skin Enterprises Inc shares is currently 2.9%.
To buy shares in NU Skin Enterprises Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in NU Skin Enterprises Inc are currently trading at $52.9, giving the company a market capitalisation of £1.92bn.
Here are the trading details for NU Skin Enterprises Inc:
Based on an overall assessment of its quality, value and momentum, NU Skin Enterprises Inc is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in NU Skin Enterprises Inc are currently priced at $52.9. At that level they are trading at 22% discount to the analyst consensus target price of 0.00.
Analysts covering NU Skin Enterprises Inc currently have a consensus Earnings Per Share (EPS) forecast of 4.001 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NU Skin Enterprises Inc. Over the past six months, the relative strength of its shares against the market has been -18.98%. At the current price of $52.9, shares in NU Skin Enterprises Inc are trading at 1.26% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NU Skin Enterprises Inc PE ratio based on its reported earnings over the past 12 months is 14.28. The shares are currently trading at $52.9.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
NU Skin Enterprises Inc's management team is headed by:
Here are the top five shareholders of NU Skin Enterprises Inc based on the size of their shareholding:
